| 注册
首页|期刊导航|中国组织工程研究与临床康复|高危角膜移植后免疫排斥反应与颈淋巴结切除

高危角膜移植后免疫排斥反应与颈淋巴结切除

凌士奇 张慧 林浩添 徐建刚 邝文辉

中国组织工程研究与临床康复2008,Vol.12Issue(5):996-1000,5.
中国组织工程研究与临床康复2008,Vol.12Issue(5):996-1000,5.

高危角膜移植后免疫排斥反应与颈淋巴结切除

Cervical lymphadenectomy and immune rejection after high-risk corneal allograft

凌士奇 1张慧 2林浩添 2徐建刚 3邝文辉2

作者信息

  • 1. 广州市儿童医院眼科,广东省广州市,510120
  • 2. 中山大学中山眼科中心(眼科学国家重点试验室),广东省广州市,510060
  • 3. 昆明医学院第一附属医院眼科,云南省昆明市,650032
  • 折叠

摘要

Abstract

BACKGROUND: Cervical lymph nodes are draining region of cornea. It is believed that aqueous fluid goes through a minor pathway named uveoscleral drainage, which will allow passage of antigen-presenting cells (APC) directly to the draining lymph nodes and induce allograft rejection after keratoplasty.OBJECTIVE: To explore the inhibitory effects of cervical lymphadenectomy in alkali induced high-risk corneal transplantation.DESIGN: A randomized controlled animal experiment.SETTING: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University.MATERIALS: The experiment was performed in the State Key Laboratory of Ophthalmology (No. 2006DA105054), Zhongshan Ophthalmic Center, Sun Yat-sen University from May 2005 to February 2007. 144 male animals (1-2 months old) including 104 SD rats and 40 Wistar rats were provided by the animal experimental center of Sun Yat-sen University. Sandwich enzyme-linked immunosorbent assay (ELISA) kits for interleukin-2 (IL-2) and interferon-γ (IFN-γ) were brought from BioSource International company (USA). The animal treatment in the experiment was accorded with the statement in Association for Research in Vision and Ophthalmology (ARVO) for animals.METHODS: With the SD rats as recipients, and Wistar rats as donors, all rats were subjected to corneal allografting. The recipient rats were randomly divided into 4 groups (n=20): group A (control group) which underwent corneal transplantation; group B which was subjected to bilateral cervical lymphadenectomy; group C, corneal transplantation 21 days after the alkali burn injury; group D, cervical lymphadenectomy following group C. The immune rejection of grafts was evaluated by detecting the expression of IFN-γ and IL-2 using ELISA. The time when allograft rejection occurred was recorded and mean survival time (MST) was compared among the groups. The development of corneal inflammation and new vessels was examined by slit lamp microscope and histopathological examination.MAIN OUTCOME MEASURES: ①The development of corneal inflammation after corneal alkaline burns. ②MST of rats in each group following transplant. ③The expression of IL-2 and IFN-γ in grafts of each group. RESULTS: ①Normal rat cornea was transparent without inflammation or neovascularization. There were many inflammatory cells invading to stroma on day 3 after burn. Then, the inflammation of cornea resolved gradually 3 weeks after the burn, but corneal neovascularization reached the peak at that time. Corneal blood vessels regressed completely at the end of 8 weeks after the burn. ②The MST of group A, B, C, and D was (10.40±1.14), (46.30±9.46), (7.00±1.58), and (15.00±3.39) days, respectively. Compared with the group A, the MST of group B was significantly longer (P < 0.05), and the MST of grafts in group D was also significantly longer than group C (P < 0.05). ③The expression of IFN-γ and IL-2 proteins was absent in group B. Compared with group C, the expression of IL-2 and IFN-γ proteins in group D significantly decreased on days 3, 7, 10, and 14 after keratoplasty (P < 0.05). CONCLUSION: Cervical lymphadenectomy therapy can effectively inhibit corneal allograft rejection in normal and high-risk corneal beds after alkali burn injury.

关键词

高危角膜移植/免疫排斥/颈淋巴结切除

分类

医药卫生

引用本文复制引用

凌士奇,张慧,林浩添,徐建刚,邝文辉..高危角膜移植后免疫排斥反应与颈淋巴结切除[J].中国组织工程研究与临床康复,2008,12(5):996-1000,5.

基金项目

国家自然科学基金(30700927, 30600697) (30700927, 30600697)

广东省自然科学基金(06300677) (06300677)

中国博士后科学基金(20050384) (20050384)

the National Natural Science Foundation of China, No. 30700927, 30600697 ()

the Natural Science Foundation of Guangdong Province, No. 06300677 ()

the Postdoctoral Foundation of China, No. 20050384 ()

中国组织工程研究与临床康复

OA北大核心CSCDCSTPCD

2095-4344

访问量0
|
下载量0
段落导航相关论文